Text + image

<h2 style="white-space:pre-line;text-align:left">Heart Failure Research</h2>
<p style="text-align:left">Medilife leads groundbreaking research in heart failure, developing innovative treatments to improve patient outcomes. We're exploring novel drug delivery and regenerative medicine.</p>
<p style="text-align:left">Our commitment to innovation drives better management strategies and therapies. We collaborate globally to accelerate R&amp;D and improve the quality of life for heart failure patients.</p>

Medilife Innovations

Medilife Innovations Group Corp. is a forward-thinking startup driving innovation in bio-health.

We use Samsung ultrasound devices to provide services to nearly 1,000 pregnant women annually. These devices contribute to the diagnosis and prevention of various fetal diseases.

We provide cord blood and cord tissue storage services that offer access to mesenchymal stem cells, endothelial progenitor cells, epithelial progenitor cells, and more. These cells are being researched for their potential applications in regulating the immune system and treating vascular damage.

We are developing a new app that will:
Safely guide women through pregnancy and post-pregnancy stages.
Serve as a trustworthy resource hub and support tool.
Improve health outcomes for women and their families.

We provide ultrasound services to nearly 1,000 pregnant women annually. Leveraging AI, we aim to develop a new system that processes this extensive data to enhance diagnostic accuracy and improve disease prevention, ensuring better patient outcomes.